CYP 1.82% 27.0¢ cynata therapeutics limited

Ann: Investor Presentation, page-296

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 216 Posts.
    lightbulb Created with Sketch. 35
    Did you read in the article

    1. Reference to Yamanaka's iPSC patents challenges (dismissed)
    2. WARF patents
    3. James Thomson patent challenge

    There was zero prior art from Mesoblast mentioned in any of this. They would laugh them out of court on iPSCs


 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.